HSDT - Helius Medical Technologies Operating income before deduction of amortization
Helius Medical (HSDT) demonstrates weak operational momentum, requiring constant capital injections. The development of portable systems for stroke rehabilitation and the expansion of testing for other pathologies mitigate overall risks. The current EBITDA_Co level confirms profit dynamics, where the value 0.00 represents the current metric. The company's revenues are based on the sale of PoNS stimulators for the restoration of patients' neural connections.
Summary analytical data breakdowns for Helius Medical Technologies (HSDT)
- stock price and consensus target price:
- market capitalization statistics:
- balance sheet equity data:
- company total debt and liquidity indicators:
All Debt to Shareholders' Equity Ratio Helius Medical|HSDT - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Helius Medical Technologies, Inc.|HSDT - Company Aggregate Debts|Debts to Book Value Helius Medical Technologies|HSDT - Company Long-Term Debts|Company Short-Term Indebtedness Helius Medical Technologies|Interim Coverage Ratio heliusmedical.com
- business earnings and investment ratios data:
HSDT - Net Profit|Future Profit Helius Medical|HSDT - P/E Multiple|Forward P/E Multiple Helius Medical Technologies, Inc.|HSDT - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Helius Medical Technologies|HSDT - Operating profit EBITDA|Earnings per share for the trailing year Helius Medical Technologies|HSDT - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months heliusmedical.com|HSDT - Earnings growth in current year|Projected earnings per share growth rate for next year Helius Medical
Summary company analytics:Helius Medical
This metric captures the daily cash balance of operating income, reflecting the real balance of supply and demand excluding depreciation factors. By analyzing the EBITDA statistics of Helius Medical (HSDT), an investor can assess the scaling efficiency of PoNS systems in US clinics; however, one must distinguish between temporary liquidity spikes and the long-term business growth trend of Helius Medical to avoid overpaying for the asset.
Who Helius Medical competes with
Biogen Idec - Profit before payment of interest, taxes and amortization|Neurocrine Biosciences - Operating profit EBITDA|Operating income before deduction of amortization regencellbioscience.com RGC|AXSM (Axsome Therapeutics, Inc.) - Operating profit before deduction of amortization|ACADIA Pharma (ACAD) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Xenon Pharmaceuticals Inc|Viking Therapeutics Corp (VKTX) - Operating income before deduction of amortization|Operating profit before deduction of amortization SUPN (Supernus Pharmaceuticals)|CPRX (catalystpharma.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Denali Therapeutics Inc. DNLI|HRMY - Operating profit before deduction of amortization|Biohaven Pharmaceutical - Operating profit EBITDA|Profit before interest, taxes and amortization Amylyx Corp|TRVI: Operating profit EBITDA|Operating profit before amortization PRAX|AVXL (Anavex Life Sciences Corp.) - Operating profit EBITDA|CeriBell Inc (CBLL) - Operating income before deduction of amortization|Operating profit EBITDA PRTA|Operating profit before deduction of amortization alector.com ALEC|Operating profit EBITDA ANNX (Annexon, Inc.)|Operating profit EBITDA Omeros Corp OMER|NGNE - Profit before payment of interest, taxes and amortization|ACIU: Profit before payment of interest, taxes and amortization|VYGR: Operating profit EBITDA|Neumora Corp - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Scilex Holding Company|tevogen.com (TVGN) - Operating income before deduction of amortization|Operating profit EBITDA ACOG|Cognition Therapeutics Inc. - Operating profit before amortization|Inhibikase - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization SAVA (Cassava Pharma)|ASRT - Profit before payment of interest, taxes and amortization|COYA (Coya Therapeutics, Inc.) - Operating profit before amortization|VTGN: Operating profit EBITDA|Profit before interest, taxes and amortization Ovid Therapeutics (OVID)|Operating profit before deduction of amortization ABOS|Operating profit EBITDA CervoMed Corporation|Profit before payment of interest, taxes and amortization Alterity Therapeutics (ATHE)|CLNN (clene.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization PepGen PEPG|Jupiter Neurosciences, Inc. (JUNS) - Profit before interest, taxes and amortization|Relmada - Operating profit EBITDA|Income before deduction of interest, taxes and amortization ANVS (Annovis Bio Corporation)|GRCE: Operating profit EBITDA|Profit before interest, taxes and amortization fireflyneuro.com (AIFF)|Profit before payment of interest, taxes and amortization ANEW Medical|Profit before payment of interest, taxes and amortization NRSN|Operating profit EBITDA RVPH|Operating income before deduction of amortization metaviatx.com|NeurAxis, Inc. - Operating profit before deduction of amortization|Operating profit EBITDA Passage Bio Inc. PASG|NEUP - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Minerva Neurosciences Inc NERV|ATHA (Athira) - Operating profit before deduction of amortization|Addex - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Alzamend Neuro Inc.|Operating profit before deduction of amortization Cyclerion (CYCN)|Operating profit EBITDA PTIX|KTTA - Profit before interest, taxes and amortization|Operating profit EBITDA CRGT (Cortigent)|ATXI: Operating profit before amortization|Brainstorm Cell - Operating profit EBITDA|Operating income before deduction of amortization caratherapeutics.com CARA|CHRO: Operating profit EBITDA|Operating profit before deduction of amortization Eliem Therapeutics Inc.|ITCI (Intra-Cellular Therapies Inc.) - Operating profit EBITDA|Operating profit EBITDA Longboard|Profit before payment of interest, taxes and amortization Marinus Pharmaceuticals (MRNS)|Profit before payment of interest, taxes and amortization NKGN (nkgenbiotech.com)|Operating profit EBITDA NRBO (NeuroBo Pharmaceuticals, Inc.)|Income before deduction of interest, taxes and amortization SAGE|SNPX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Trevena Inc TRVN|VIGL: Operating profit EBITDA|Operating profit before amortization WENA|Operating profit before deduction of amortization CERE
